Treatment protocols for infections of vascular catheters

Biofilms, Infection, and Antimicrobial Therapy

Volumn , Issue , 2005, Pages 409-425

  Lewis, Russell E ^a   Raad, Issam I ^b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 39649106199     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (55)

1. Jarvis, W.R., Edwards, J.R., Culver, D.H., et al., Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am. J. Med. 91, 185S-191S, 1991.
2. Banerjee, S.N., Emori, T.G., Culver, D.H., et al., Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am. J. Med. 91, 86S-89S, 1991.
3. Raad, I.I., and Hanna, H.A., Intravascular catheter-related infections: new horizons and recent advances. Arch. Intern. Med. 162, 871-878, 2002.
4. Mermel, L.A., Farr, B.M., Sherertz, R.J., et al., Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 32, 1249-1272, 2001.
5. O’Grady, N.P., Alexander, M., Dellinger, E.P., et al., Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 51, 1-29, 2002.
6. Edgeworth, J.D., Treacher, D.F., and Eykyn, S.J., A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit. Care Med. 27, 1421-1428, 1999.
7. Richards, M.J., Edwards, J.R., Culver, D.H., and Gaynes, R.P., Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect. Control. Hosp. Epidemiol. 21, 510-515, 2000.
8. Gudlaugsson, O., Gillespie, S., Lee, K., et al., Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 37, 1172-1177, 2003.
9. McNeil, M.M., Nash, S.L., Hajjeh, R.A., et al., Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin. Infect. Dis. 33, 641-647, 2001.
10. Herrmann, M., Vaudaux, P.E., Pittet, D., et al., Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J. Infect. Dis. 158, 693-701, 1988.
11. Raad, I., Costerton, W., Sabharwal, U., Sacilowski, M., Anaissie, E., and Bodey, G.P., Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J. Infect. Dis. 168, 400-407, 1993.
12. Sherertz, R.J., Raad, I.I., Belani, A., et al., Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J. Clin. Microbiol. 28, 76-82, 1990.
13. Parsek, M.R., and Singh, P.K., Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol. 57, 677-701, 2003.
14. Pascual, A., Ramirez de Arellano, E., and Perea, E.J., Activity of glycopeptides in combination with amikacin or rifampin against Staphylococcus epidermidis biofilms on plastic catheters. Eur. J. Clin. Microbiol. Infect. Dis. 13, 515-517, 1994.
15. Pascual, A., Martinez-Martinez, L., Ramirez de Arellano, E., and Perea, E.J., Susceptibility to antimicrobial agents of Pseudomonas aeruginosa attached to siliconized latex urinary catheters. Eur. J. Clin. Microbiol. Infect. Dis. 12, 761-765, 1993.
16. Pascual, A., Ramirez de Arellano, E., Martinez Martinez, L., and Perea, E.J., Effect of polyurethane catheters and bacterial biofilms on the in-vitro activity of antimicrobials against Staphylococcus epidermidis. J. Hosp. Infect. 24, 211-218, 1993.
17. Ramage, G., VandeWalle, K., Bachmann, S.P., Wickes, B.L., and Lopez-Ribot, J.L., In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob. Agents Chemother. 46, 3634-3636, 2002.
18. McGee, D.C., and Gould, M.K., Preventing complications of central venous catheterization. N. Engl. J. Med. 348, 1123-1133, 2003.
19. Maki, D.G., Weise, C.E., and Sarafin, H.W., A semiquantitative culture method for identifying intravenous-catheter-related infection. N. Engl. J. Med. 296, 1305-1309, 1977.
20. Siegman-Igra, Y., Anglim, A.M., Shapiro, D.E., Adal, K.A., Strain, B.A., and Farr, B.M., Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. J. Clin. Microbiol. 35, 928-936, 1997.
21. Capdevila, J.A., Planes, A.M., Palomar, M., et al., Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis. Eur. J. Clin. Microbiol. Infect. Dis. 11, 403-407, 1992.
22. Blot, F., Nitenberg, G., Chachaty, E., et al., Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheralblood cultures. Lancet 354, 1071-1077, 1999.
23. Blot, F., Schmidt, E., Nitenberg, G., et al., Earlier positivity of central-venousversus peripheral-blood cultures is highly predictive of catheter-related sepsis. J. Clin. Microbiol. 36, 105-109, 1998.
24. Raad, I., Hanna, H.A., Alakech, B., Chatzinikolaou, I., Johnson, M.M., and Tarrand, J., Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann. Intern. Med. 140, 18-25, 2004.
25. Kite, P., Dobbins, B.M., Wilcox, M.H., and McMahon, M.J., Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal. Lancet 354, 1504-1507, 1999.
26. Kite, P., Dobbins, B.M., Wilcox, M.H., et al., Evaluation of a novel endoluminal brush method for in situ diagnosis of catheter related sepsis. J. Clin. Pathol. 50, 278-282, 1997.
27. Raad, I., Davis, S., Khan, A., Tarrand, J., Elting, L., and Bodey, G.P., Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect. Control Hosp. Epidemiol. 13, 215-221, 1992.
28. Raad, I., Narro, J., Khan, A., Tarrand, J., Vartivarian, S., and Bodey, G.P., Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur. J. Clin. Microbiol. Infect. Dis. 11, 675-682, 1992.
29. Phillips, M.S., and von Reyn, C.F., Nosocomial infections due to nontuberculous mycobacteria. Clin. Infect. Dis. 33, 1363-1374, 2001.
30. Chang, F.Y., Peacock, J.E., Jr., Musher, D.M., et al., Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 333-339, 82, 2003.
31. Carratala, J., The antibiotic-lock technique for therapy of ‘highly needed’ infected catheters. Clin. Microbiol. Infect. 8, 282-289, 2002.
32. Dannenberg, C., Bierbach, U., Rothe, A., Beer, J., and Korholz, D., Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J. Pediatr. Hematol. Oncol. 25, 616-621, 2003.
33. Messing, B., Peitra-Cohen, S., Debure, A., Beliah, M., and Bernier, J.J., Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J. Parenter. Enteral. Nutr. 12, 185-189, 1988.
34. Messing, B., Catheter-sepsis during home parenteral nutrition: use of the antibiotic-lock technique. Nutrition 14, 466-468, 1998.
35. Longuet, P., Douard, M.C., Maslo, C., Benoit, C., Arlet, G., and Leport, C., Limited efficacy of antibiotic lock technique in catheter related bacteremia of totally implanted ports in HIV infected and oncology patients. In: Programs and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA: ASM Press, 1995.
36. Krishnasami, Z., Carlton, D., Bimbo, L., et al., Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int. 61, 1136-1142, 2002.
37. Johnson, D.C., Johnson, F.L., and Goldman, S., Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients. Pediatr. Infect. Dis. J. 13, 930-931, 1994.
38. Capdevila, J.A., Segarra, A., Planes, A.M., et al., Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol. Dial. Transplant. 8, 231-234, 1993.
39. Capdevila, J.A., Barbera, J., and Gavalda, J., Diagnosis and conservative management of infection related to long term venous catheterization in AIDS patients. In: Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Orlando, FL: ASM Press, 1994.
40. Benoit, J.L., Carandang, G., Sitrin, M., and Arnow, P., Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin. Infect. Dis. 24, 743-744, 1997.
41. Krzywda, E.A., Andris, D.A., Edmiston, Jr. C.E., and Quebbeman, E.J., Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect. Control. Hosp. Epidemiol. 16, 596-598, 1995.
42. Domingo, P., Fontanet, A., Sanchez, F., Allende, L., and Vazquez, G., Morbidity associated with long-term use of totally implantable ports in patients with AIDS. Clin. Infect. Dis. 29, 346-351, 1999.
43. Veenstra, D.L., Saint, S., Saha, S., Lumley, T., and Sullivan, S.D., Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 281, 261-267, 1999.
44. Maki, D.G., Stolz, S.M., Wheeler, S., and Mermel, L.A., Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann. Intern. Med. 127, 257-266, 1997.
45. Walder, B., Pittet, D., and Tramer, M.R., Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect. Control Hosp. Epidemiol. 23, 748-756, 2002.
46. Raad, I., Darouiche, R., Dupuis, J., et al., Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann. Intern. Med. 127, 267-274, 1997.
47. Darouiche, R.O., Raad, I.I., Heard, S.O., et al., A comparison of two antimicrobialimpregnated central venous catheters. Catheter Study Group. N. Engl. J. Med. 340, 1-8, 1999.
48. Chatzinikolaou, I., Hanna, H., Graviss, L., et al., Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance. Infect. Control. Hosp. Epidemiol. 24, 961-963, 2003.
49. Hanna, H.A., Raad, I.I., Hackett, B., et al., Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients. Chest 124, 1030-1038, 2003.
50. Veenstra, D.L., Saint, S., and Sullivan, S.D., Cost-effectiveness of antisepticimpregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 282, 554-560, 1999.
51. Maki, D.G., Cobb, L., Garman, J.K., Shapiro, J.M., Ringer, M., and Helgerson, R.B., An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am. J. Med. 85, 307-314, 1988.
52. Henrickson, K.J., Axtell, R.A., Hoover, S.M., et al., Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial. J. Clin. Oncol. 18, 1269-1278, 2000.
53. Spafford, P.S., Sinkin, R.A., Cox, C., Reubens, L., and Powell, K.R., Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee. MMWR 44, 1-13, 1994.
54. Raad, I., Buzaid, A., Rhyne, J., et al., Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin. Infect. Dis. 25, 149-151, 1997.
55. Chatzinikolaou, I., Zipf, T.F., Hanna, H., et al., Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin. Infect. Dis. 36, 116-119, 2003.